X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
saquinavir (34) 34
humans (31) 31
hiv infections - drug therapy (20) 20
pharmacology & pharmacy (15) 15
ritonavir (14) 14
index medicus (13) 13
hiv protease inhibitors - therapeutic use (11) 11
hiv (10) 10
hiv protease inhibitors - economics (9) 9
protease inhibitors (9) 9
adult (8) 8
anti-hiv agents - therapeutic use (8) 8
hiv protease inhibitors - pharmacokinetics (8) 8
male (8) 8
aids (7) 7
drug therapy (7) 7
hiv infection (7) 7
hiv infections - economics (7) 7
anti-hiv agents - economics (6) 6
cost-benefit analysis (6) 6
drug interactions (6) 6
drug therapy, combination (6) 6
female (6) 6
infectious diseases (6) 6
saquinavir - pharmacokinetics (6) 6
saquinavir - therapeutic use (6) 6
anti-hiv agents (5) 5
antiviral agents (5) 5
hiv protease inhibitors - administration & dosage (5) 5
hiv protease inhibitors - pharmacology (5) 5
immunology (5) 5
pharmacokinetics (5) 5
saquinavir - economics (5) 5
saquinavir - pharmacology (5) 5
acquired immune deficiency syndrome--aids (4) 4
anti-hiv agents - pharmacology (4) 4
antiretroviral therapy, highly active - economics (4) 4
antivirals (4) 4
chemical properties (4) 4
chemistry, analytical (4) 4
drug costs (4) 4
drug resistance (4) 4
drug-delivery (4) 4
engineering, chemical (4) 4
highly active antiretroviral therapy (4) 4
human immunodeficiency virus (4) 4
human immunodeficiency virus--hiv (4) 4
in-vitro (4) 4
infection (4) 4
isoquinolines - therapeutic use (4) 4
microvascular endothelial-cells (4) 4
protease inhibitor (4) 4
research (4) 4
saquinavir - administration & dosage (4) 4
saquinavir - chemistry (4) 4
saquinavir mesylate (4) 4
administration, oral (3) 3
amprenavir (3) 3
analysis (3) 3
antiretroviral agents (3) 3
antiviral agents - therapeutic use (3) 3
barrier (3) 3
biological availability (3) 3
blood-brain barrier (3) 3
blood–brain barrier (3) 3
cd4 lymphocyte count (3) 3
chemistry, medicinal (3) 3
clinical trials as topic (3) 3
computer simulation (3) 3
disease transmission (3) 3
drug (3) 3
drug monitoring (3) 3
drug-resistance (3) 3
drugs (3) 3
efavirenz (3) 3
health care costs (3) 3
hiv - drug effects (3) 3
hiv infections - blood (3) 3
hiv protease inhibitors - adverse effects (3) 3
hiv protease inhibitors - chemistry (3) 3
hiv-1 (3) 3
hiv-1 - drug effects (3) 3
hiv-1 protease (3) 3
human plasma (3) 3
human-immunodeficiency-virus (3) 3
immunodeficiency-virus-infection (3) 3
in-vivo (3) 3
indinavir (3) 3
isoquinolines - economics (3) 3
medical research (3) 3
medicine (3) 3
methods (3) 3
microbiology (3) 3
middle aged (3) 3
multidisciplinary sciences (3) 3
nelfinavir (3) 3
p-glycoprotein (3) 3
patient compliance (3) 3
performance liquid-chromatography (3) 3
permeability (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
PharmacoEconomics, ISSN 1170-7690, 04/2000, Volume 17, Issue 4, pp. 325 - 330
Since 1997, expert panel guidelines for HIV care have recommended the use of combination antiretroviral therapy with at least 3 antiretroviral drugs. Several... 
Stavudine, therapeutic use | Lamivudine, therapeutic use | Efavirenz, therapeutic use | Zalcitabine, therapeutic use | Zidovudine, therapeutic use | Research and development | Didanosine, therapeutic use | Delavirdine mesylate, therapeutic use | Ritonavir, therapeutic use | Cost effectiveness | Lamivudine/zidovudine, therapeutic use | Antivirals, therapeutic use | Nelfinavir, therapeutic use | Pharmacoeconomics | Saquinavir, therapeutic use | Nevirapine, therapeutic use | Amprenavir, therapeutic use | Non nucleoside reverse transcriptase inhibitors, t | Protease inhibitors, therapeutic use | Abacavir, therapeutic use | HIV infections, treatment | Indinavir, therapeutic use | Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | INDINAVIR | TRIAL | LAMIVUDINE | COUNTS | IMPACT | ZIDOVUDINE | IMMUNODEFICIENCY-VIRUS INFECTION | AIDS | PHARMACOLOGY & PHARMACY | ANTIRETROVIRAL THERAPY | LESS | Antiviral Agents - therapeutic use | HIV Infections - economics | Cost-Benefit Analysis | Humans | Reverse Transcriptase Inhibitors - economics | HIV Infections - drug therapy | Antiviral Agents - economics | Protease Inhibitors - economics | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | zidovudine; Nelfinavir; Nevirapine; Non nucleoside reverse transcriptase inhibitors; Pharmacoeconomics; Protease inhibitors; Research and development; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | Abacavir; Amprenavir; Antivirals; Cost effectiveness; Delavirdine mesylate; Didanosine; Efavirenz; HIV infections; Indinavir; Lamivudine; Lamivudine
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140074
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2001, Volume 27, Issue 1, pp. 14 - 19
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2007, Volume 51, Issue 9, pp. 3361 - 3363
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
DRUG | HIV-1 | THIN-LAYER-CHROMATOGRAPHY | PERFORMANCE | SAQUINAVIR | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PROTEASE INHIBITORS | RITONAVIR | HIV Infections - blood | Nevirapine - blood | Humans | Adult | Female | Drug Monitoring - economics | Anti-HIV Agents - blood | Chromatography, High Pressure Liquid | Drug Monitoring - methods | Immunochemistry | Chromatography | Antiviral Agents
Journal Article
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 02/1998, Volume 55, Issue 3, pp. 233 - 254
Journal Article